Reproductive Health
Active Resources: 12
Webinar Recordings
-
6/2/2020
Slide Sets
-
4/7/2020
Toolkits
-
1/20/2020
-
2/22/2016
Antiretroviral Guidelines
-
12/24/2019
Online Training
-
12/4/2019
Clinical Reference Tools
-
5/3/2017 (reviewed: 5/3/2017)
Charts, Tables & Posters
-
3/10/2017
-
9/4/2015
Reports
-
8/27/2015
Primary Care Guidelines
-
6/22/2012
Archive Resources: 7
Coinfection Guidelines (Hep, TB, STIs)
-
6/5/2015
Videos
-
4/1/2015 (reviewed: 5/8/2019)
-
4/1/2015 (reviewed: 5/8/2019)
Prevention & Testing Guidelines (PEP, PrEP, PWP)
-
12/11/2014
Toolkits
-
8/1/2014 (reviewed: 11/30/2015)
Webinar Recordings
-
4/17/2014 (reviewed: 5/8/2019)
Manuals
-
11/1/2013
Articles: 4
-
AETCs at the 2018 Ryan White Conference
The AETC Program was well represented at the 2018 National Ryan White Conference on HIV Care & Treatment. The AETC National Coordinating Resource Center exhibited an array of AETC Program developed resources and promotional items.
TitleSession IDTypePresenters/ PanelistsDate/timeHIV and... -
Tenofovir Alafenamide (TAF) and Darunavir/Cobicistat in Pregnant Women
Two pharmacokinetic studies from AIDS 2018 help elucidate the disposition of tenofovir alafenamide (TAF) and cobicistat-boosted darunavir during pregnancy.
The IMPAACT P1026s study examined plasma concentrations of TAF with and without cobicistat in 43 pregnant women. For women taking...
-
Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy
Although DTG currently is not a desirable medication for women to take pre-conception (see Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects), findings from the DolPHIN study suggest that it may be a very useful agent for women who start ART during late pregnancy....
-
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Three studies presented at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) explored the pharmacokinetics of antiretrovirals administered during pregnancy. These studies support the use of standard-dose efavirenz, once-daily dolutegravir, and BID ritonavir-boosted...